N. Finnberg

发表

Activating FOXO3a, NF-kappaB and p53 by targeting IKKs: An effective multi-faceted targeting of the tumor-cell phenotype?

W. El-Deiry, N. Finnberg, 2004, Cancer biology & therapy.

TRAIL receptor deletion in mice suppresses the inflammation of nutrient excess.

C. Trautwein, G. Gores, N. LeBrasseur, 2015, Journal of hepatology.

TRAIL-R deficiency in mice promotes susceptibility to chronic inflammation and tumorigenesis.

A. Klein-Szanto, W. El-Deiry, Andres J Klein-Szanto, 2008, The Journal of clinical investigation.

Tissue TGF-β expression following conventional radiotherapy and pulsed low-dose-rate radiation

W. El-Deiry, Lanlan Zhou, Yanqun Dong, 2017, Cell cycle.

Death Receptor 5 Signaling Promotes Hepatocyte Lipoapoptosis*

G. Gores, W. El-Deiry, S. Kaufmann, 2011, The Journal of Biological Chemistry.

Preliminary observations indicate variable patterns of plasma 5-fluorouracil (5-FU) levels during dose optimization of infusional 5-FU in colorectal cancer patients

W. El-Deiry, J. Liao, C. L. Kline, 2011, Cancer biology & therapy.

PIGN gene expression aberration is associated with genomic instability and leukemic progression in acute myeloid leukemia with myelodysplastic features

Anna C. Salzberg, T. Abraham, Y. Kawasawa, 2017, Oncotarget.

Inefficient boosting of antitumor CD8+ T cells by dendritic-cell vaccines is rescued by restricting T-cell cytotoxic functions

W. El-Deiry, R. Perret, F. Ronchese, 2012, Oncoimmunology.

Detection of DSS-induced gastrointestinal mucositis in mice by non-invasive optical near-infrared (NIR) imaging of cathepsin activity

W. El-Deiry, N. Finnberg, Yvette Liu, 2013, Cancer biology & therapy.

TRAIL death receptors as tumor suppressors and drug targets

W. El-Deiry, N. Finnberg, 2008, Cell cycle.

The effects of antioxidants on gene expression following gamma-radiation (GR) and proton radiation (PR) in mice in vivo

W. El-Deiry, C. Wambi, N. Finnberg, 2013, Cell cycle.

Targeting TRAIL in the treatment of cancer: new developments

W. El-Deiry, B. Lim, N. Finnberg, 2015, Expert opinion on therapeutic targets.

Targeting of Chk2 as a countermeasure to dose-limiting toxicity triggered by topoisomerase-II (TOP2) poisons

Shengliang Zhang, P. Gokare, N. Motoyama, 2016, Oncotarget.

Selective TRAIL-Induced Apoptosis in Dysplastic Neoplasia of the Colon May Lead to New Neoadjuvant or Adjuvant Therapies

W. El-Deiry, N. Finnberg, 2006, Clinical Cancer Research.

DR5 Knockout Mice Are Compromised in Radiation-Induced Apoptosis

S. Lowe, T. Mak, T. Burns, 2005, Molecular and Cellular Biology.

Application of 3D tumoroid systems to define immune and cytotoxic therapeutic responses based on tumoroid and tissue slice culture molecular signatures

Luigi Grasso, W. El-Deiry, Avital Lev, 2017, Oncotarget.

THE ATTENUATION OF THE P53 RESPONSE TO DNA DAMAGE IN RODENT LIVER PRENEOPLASTIC ENZYME- ALTERED FOCI

N. Finnberg, 2003 .

ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosis.

N. Hockstein, W. El-Deiry, E. Celis, 2014, The Journal of clinical investigation.

Colon Stem Cells in Colorectal Cancer

W. El-Deiry, N. Finnberg, V. Prabhu, 2015 .

Characterizing the role of MDM2 in diethylnitrosamine induced acute liver damage and development of pre-neoplastic lesions.

U. Stenius, J. Högberg, N. Finnberg, 2003, Carcinogenesis.

Studying p53-dependent cell death in vitro and in vivo.

W. El-Deiry, Kageaki Kuribayashi, N. Finnberg, 2008, Methods in enzymology.

Reduced ATM kinase activity and an attenuated p53 response to DNA damage in carcinogen-induced preneoplastic hepatic lesions in the rat.

Ilona Silins, U. Stenius, J. Högberg, 2001, Carcinogenesis.

Paclitaxel and velcade: The rationale for a combo

W. El-Deiry, N. Finnberg, 2005 .

The relative contribution of pro-apoptotic p53-target genes in the triggering of apoptosis following DNA damage in vitro and in vivo

W. El-Deiry, G. Zambetti, J. R. Jeffers, 2011, Cell cycle.

P53-dependent induction of serine proteases in irradiated mouse colon

W. El-Deiry, E. Bernhard, N. Finnberg, 2004, Cancer biology & therapy.

Heterozygous p53-deficient (+/-) mice develop fewer p53-negative preneoplastic focal liver lesions in response to treatment with diethylnitrosamine than do wild-type (+/+) mice.

U. Stenius, J. Högberg, N. Finnberg, 2004, Cancer letters.

ANIMAL MODELS OF CANCER BIOLOGY

Natalia Ignatenko, N. Lee, D. Stairs, 2015, Cancer growth and metastasis.

Sorafenib and Quinacrine Target Anti-Apoptotic Protein MCL1: A Poor Prognostic Marker in Anaplastic Thyroid Cancer (ATC)

W. El-Deiry, D. Dicker, P. Gokare, 2016, Clinical Cancer Research.

Reduced cell death, invasive and angiogenic features conferred by BRCA1-deficiency in mammary epithelial cells transformed with H-Ras

W. El-Deiry, D. Dicker, Wensheng Yang, 2009, Cancer biology & therapy.

Xenobiotics modulate the p53 response to DNA damage in preneoplastic enzyme-altered foci in rat liver; effects of diethylnitrosamine and phenobarbital.

U. Stenius, J. Högberg, N. Finnberg, 2000, Toxicological sciences : an official journal of the Society of Toxicology.

Protective Effects of Dietary Antioxidants on Proton Total-Body Irradiation-Mediated Hematopoietic Cell and Animal Survival

W. El-Deiry, J. Lewis-Wambi, James G. Davis, 2009, Radiation research.

Gamma-radiation (GR) triggers a unique gene expression profile associated with cell death compared to proton radiation (PR) in mice in vivo

C. Wambi, N. Finnberg, J. Ware, 2008, Cancer biology & therapy.

High-resolution imaging and antitumor effects of GFP(+) bone marrow-derived cells homing to syngeneic mouse colon tumors.

Zachary B. Rodgers, W. El-Deiry, D. Dicker, 2010, The American journal of pathology.

P53 represses pyrimidine catabolic gene dihydropyrimidine dehydrogenase (DPYD) expression in response to thymidylate synthase (TS) targeting

W. El-Deiry, M. Murphy, P. Gokare, 2017, Scientific Reports.

Abstract 2926: DR5-targeting sensitizes Lgr5+ stem cells to p53 and Chk2-dependent chemotherapy-induced cell death and produces dose-limiting gastrointestinal toxicity (GIT)

W. El-Deiry, P. Gokare, N. Motoyama, 2015 .

Noninvasive fluorescence imaging of cell death in fresh human colon epithelia treated with 5-fluorouracil, CPT-11 and/or TRAIL

E. Furth, W. El-Deiry, Seok-Hyun Kim, 2005, Cancer biology & therapy.

Agonists of the TRAIL Death Receptor DR5 Sensitize Intestinal Stem Cells to Chemotherapy-Induced Cell Death and Trigger Gastrointestinal Toxicity.

W. El-Deiry, P. Gokare, N. Motoyama, 2016, Cancer research.

Selective TRAIL-Induced Apoptosis in Dysplastic Neoplasia of the ColonMay Lead to New Neoadjuvant or Adjuvant Therapies 55 Commentary onJalving

W. El-Deiry, N. Finnberg, 2006 .

Decreased survival, chronic inflammation and tumor susceptibility of irradiated DR5-null mice

W. El-Deiry, E. Bernhard, Andres J Klein-Szanto, 2006 .

Occurrence of acute myeloid leukemia in hydroxyurea-treated sickle cell disease patient

W. El-Deiry, N. Finnberg, J. Pu, 2019, Cancer biology & therapy.

P53 represses pyrimidine catabolic gene dihydropyrimidine dehydrogenase (DPYD) expression in response to thymidylate synthase (TS) targeting

W. El-Deiry, M. Murphy, P. Gokare, 2017, Scientific Reports.